BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38547750)

  • 1. CRISPR screen in regulatory T cells reveals modulators of Foxp3.
    Cortez JT; Montauti E; Shifrut E; Gatchalian J; Zhang Y; Shaked O; Xu Y; Roth TL; Simeonov DR; Zhang Y; Chen S; Li Z; Woo JM; Ho J; Vogel IA; Prator GY; Zhang B; Lee Y; Sun Z; Ifergan I; Van Gool F; Hargreaves DC; Bluestone JA; Marson A; Fang D
    Nature; 2020 Jun; 582(7812):416-420. PubMed ID: 32499641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.
    Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B
    Front Immunol; 2020; 11():1087. PubMed ID: 32636834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo.
    Hsiao HW; Hsu TS; Liu WH; Hsieh WC; Chou TF; Wu YJ; Jiang ST; Lai MZ
    Nat Commun; 2015 Feb; 6():6353. PubMed ID: 25695215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.
    Zhu F; Yi G; Liu X; Zhu F; Zhao A; Wang A; Zhu R; Chen Z; Zhao B; Fang S; Yu X; Lin R; Liang R; Li D; Zhao W; Zhang Z; Guo W; Zhang S; Ge S; Fan X; Zhao G; Li B
    J Biol Chem; 2018 Dec; 293(52):20099-20111. PubMed ID: 30389786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3 (in)stability and cancer immunotherapy.
    Mortezaee K
    Cytokine; 2024 Jun; 178():156589. PubMed ID: 38547750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T Cells: the Many Faces of Foxp3.
    Georgiev P; Charbonnier LM; Chatila TA
    J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human FOXP3 and tumour microenvironment.
    Wang J; Gong R; Zhao C; Lei K; Sun X; Ren H
    Immunology; 2023 Feb; 168(2):248-255. PubMed ID: 35689826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting or reprogramming of intra-tumoral Tregs.
    Mortezaee K
    Med Oncol; 2024 Feb; 41(3):71. PubMed ID: 38341821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treg functional stability and its responsiveness to the microenvironment.
    Barbi J; Pardoll D; Pan F
    Immunol Rev; 2014 May; 259(1):115-39. PubMed ID: 24712463
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.